Generation of mature compact ventricular cardiomyocytes from human pluripotent stem cells.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
26 05 2021
Historique:
received: 16 06 2020
accepted: 18 04 2021
entrez: 27 5 2021
pubmed: 28 5 2021
medline: 10 6 2021
Statut: epublish

Résumé

Compact cardiomyocytes that make up the ventricular wall of the adult heart represent an important therapeutic target population for modeling and treating cardiovascular diseases. Here, we established a differentiation strategy that promotes the specification, proliferation and maturation of compact ventricular cardiomyocytes from human pluripotent stem cells (hPSCs). The cardiomyocytes generated under these conditions display the ability to use fatty acids as an energy source, a high mitochondrial mass, well-defined sarcomere structures and enhanced contraction force. These ventricular cells undergo metabolic changes indicative of those associated with heart failure when challenged in vitro with pathological stimuli and were found to generate grafts consisting of more mature cells than those derived from immature cardiomyocytes following transplantation into infarcted rat hearts. hPSC-derived atrial cardiomyocytes also responded to the maturation cues identified in this study, indicating that the approach is broadly applicable to different subtypes of the heart. Collectively, these findings highlight the power of recapitulating key aspects of embryonic and postnatal development for generating therapeutically relevant cell types from hPSCs.

Identifiants

pubmed: 34039977
doi: 10.1038/s41467-021-23329-z
pii: 10.1038/s41467-021-23329-z
pmc: PMC8155185
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3155

Subventions

Organisme : CIHR
ID : FDN159937
Pays : Canada

Références

J Am Heart Assoc. 2018 Oct 16;7(20):e010378
pubmed: 30371266
Circ Res. 2020 Jun 5;126(12):1685-1702
pubmed: 32212902
J Mol Cell Cardiol. 2015 Dec;89(Pt B):287-96
pubmed: 26493106
Cell Death Differ. 2015 Jul;22(7):1106-16
pubmed: 25361084
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nat Biotechnol. 2007 Dec;25(12):1477-82
pubmed: 18037879
Circ Res. 2009 Jan 2;104(1):19-31
pubmed: 19118284
Front Physiol. 2018 Jul 19;9:959
pubmed: 30072919
Cell Metab. 2005 Jun;1(6):361-70
pubmed: 16054085
Cell Metab. 2009 Jun;9(6):512-24
pubmed: 19490906
Nat Rev Cardiol. 2020 Jun;17(6):341-359
pubmed: 32015528
Nature. 2007 Dec 6;450(7171):819-24
pubmed: 18064002
Mol Cells. 2018 Jul 31;41(7):613-621
pubmed: 29890820
J Mol Cell Cardiol. 2014 Jul;72:296-304
pubmed: 24735830
Biochim Biophys Acta. 2005 Oct 1;1736(3):163-80
pubmed: 16198626
Biochem J. 2005 Dec 1;392(Pt 2):353-62
pubmed: 16076285
Cell Stem Cell. 2011 Feb 4;8(2):228-40
pubmed: 21295278
Nat Commun. 2017 Jul 20;8(1):87
pubmed: 28729659
J Mol Cell Cardiol. 2002 Oct;34(10):1249-57
pubmed: 12425323
Genome Biol. 2018 Feb 6;19(1):15
pubmed: 29409532
J Cardiovasc Pharmacol. 2010 Aug;56(2):130-40
pubmed: 20505524
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Biomaterials. 2020 Mar;233:119741
pubmed: 31927251
Nature. 2016 Oct 20;538(7625):388-391
pubmed: 27723741
Circ Res. 2017 Dec 8;121(12):1323-1330
pubmed: 28974554
J Physiol. 2010 Jul 1;588(Pt 13):2443-54
pubmed: 20478976
Dev Cell. 2016 Dec 19;39(6):724-739
pubmed: 27997827
J Mol Cell Cardiol. 2007 Oct;43(4):388-403
pubmed: 17720186
Adv Drug Deliv Rev. 2016 Jan 15;96:110-34
pubmed: 25956564
JACC Basic Transl Sci. 2018 Feb;3(1):132-156
pubmed: 29876529
Stem Cell Reports. 2019 Oct 8;13(4):657-668
pubmed: 31564645
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18455-60
pubmed: 16352730
Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):E8372-E8381
pubmed: 28916735
Cell Stem Cell. 2021 Jan 7;28(1):96-111.e7
pubmed: 33142114
Cell Stem Cell. 2019 Sep 5;25(3):311-327
pubmed: 31491395
Cardiovasc Res. 2011 May 1;90(2):234-42
pubmed: 21257612
Nat Methods. 2013 Aug;10(8):781-7
pubmed: 23793239
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
FASEB J. 2000 Mar;14(3):495-502
pubmed: 10698964
Nat Protoc. 2019 Feb;14(2):482-517
pubmed: 30664679
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
PPAR Res. 2008;2008:279531
pubmed: 18288283
Nature. 2018 Apr;556(7700):239-243
pubmed: 29618819
Sci Rep. 2018 Jul 18;8(1):10872
pubmed: 30022098
Am J Physiol Heart Circ Physiol. 2013 Aug 15;305(4):H494-505
pubmed: 23792677
Cell Res. 2020 Jul;30(7):626-629
pubmed: 32157205
Science. 2019 Apr 12;364(6436):184-188
pubmed: 30846611
Genome Biol. 2016 Apr 27;17:75
pubmed: 27122128
Stem Cell Reports. 2014 Oct 14;3(4):594-605
pubmed: 25358788
Cell. 2014 Apr 24;157(3):565-79
pubmed: 24766806
Development. 2012 Nov;139(21):4007-19
pubmed: 22992950
BMC Bioinformatics. 2013 Jan 16;14:7
pubmed: 23323831
Cell Stem Cell. 2017 Aug 3;21(2):179-194.e4
pubmed: 28777944
Sci Rep. 2019 Mar 26;9(1):5233
pubmed: 30914743
J Mol Cell Cardiol. 2019 Jul;132:120-135
pubmed: 31082397
Development. 2011 Jan;138(1):139-48
pubmed: 21138976
Hum Mol Genet. 2013 Aug 15;22(16):3269-82
pubmed: 23595884
Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18109-14
pubmed: 17989236
Cell. 2018 Oct 4;175(2):598-599
pubmed: 30290144
Physiol Genomics. 2015 Sep;47(9):407-19
pubmed: 26126790
Am J Physiol Endocrinol Metab. 2017 Dec 1;313(6):E699-E709
pubmed: 28851734
Nat Cell Biol. 2014 Sep;16(9):829-40
pubmed: 25150979
Essays Biochem. 2010;47:53-67
pubmed: 20533900
Dev Cell. 2005 Jan;8(1):85-95
pubmed: 15621532
Nature. 2005 Mar 17;434(7031):338-45
pubmed: 15735639
Am J Med Genet C Semin Med Genet. 2013 Aug;163C(3):144-56
pubmed: 23843320
Nature. 2018 May;557(7705):439-445
pubmed: 29743679
J Mol Endocrinol. 2014 Jan 30;52(2):R125-35
pubmed: 24299741
Endocrinology. 2003 Mar;144(3):777-84
pubmed: 12586753
Nature. 2014 Jun 12;510(7504):273-7
pubmed: 24776797

Auteurs

Shunsuke Funakoshi (S)

McEwen Stem Cell Institute, University Health Network, Toronto, ON, Canada.

Ian Fernandes (I)

McEwen Stem Cell Institute, University Health Network, Toronto, ON, Canada.
Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.

Olya Mastikhina (O)

Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada.

Dan Wilkinson (D)

BlueRock Therapeutics, New York, NY, USA.

Thinh Tran (T)

Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.

Wahiba Dhahri (W)

McEwen Stem Cell Institute, University Health Network, Toronto, ON, Canada.

Amine Mazine (A)

McEwen Stem Cell Institute, University Health Network, Toronto, ON, Canada.
Institute of Biomedical Engineering, University of Toronto, Toronto, ON, Canada.

Donghe Yang (D)

McEwen Stem Cell Institute, University Health Network, Toronto, ON, Canada.
Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.

Benjamin Burnett (B)

BlueRock Therapeutics, New York, NY, USA.

Jeehoon Lee (J)

BlueRock Therapeutics, New York, NY, USA.

Stephanie Protze (S)

McEwen Stem Cell Institute, University Health Network, Toronto, ON, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.

Gary D Bader (GD)

Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
Department of Computer Science, University of Toronto, Toronto, ON, Canada.
The Donnelly Centre, University of Toronto, Toronto, ON, Canada.

Sara S Nunes (SS)

Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada.
Institute of Biomedical Engineering, University of Toronto, Toronto, ON, Canada.
Laboratory of Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Heart & Stroke/Richard Lewar Centre of Excellence, University of Toronto, Toronto, ON, Canada.

Michael Laflamme (M)

McEwen Stem Cell Institute, University Health Network, Toronto, ON, Canada.
Laboratory of Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Peter Munk Cardiac Centre, University Health Network, Toronto, ON, Canada.

Gordon Keller (G)

McEwen Stem Cell Institute, University Health Network, Toronto, ON, Canada. gordon.keller@uhnresearch.ca.
Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada. gordon.keller@uhnresearch.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH